EHA 2018 dr. Mark-David Levin (video)

dr. Mark-David Levin, werkzaam in het Albert Schweitzer ziekenhuis in Dordrecht

 

HOVON 139OBINUTUZUMAB PRE-INDUCTION ABROGATES HIGH TUMOR LYSIS RISK OF VENETOCLAX IN TREATMENT NAÏVE FCR-UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A PLANNED INTERIM ANALYSIS

 

Bekijk het abstract
 

0519HEM1178354
×

Ask Speakers

×

Medical Information Request